SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-20-022480
Filing Date
2020-08-17
Accepted
2020-08-17 14:49:33
Documents
76

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea125531-f1_universepharma.htm F-1 2727068
2 AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION ea125531ex3-1_universepharm.htm EX-3.1 17739
3 AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea125531ex3-2_universepharm.htm EX-3.2 458020
4 SPECIMEN CERTIFICATE FOR ORDINARY SHARES ea125531ex4-1_universepharm.htm EX-4.1 3505
5 FORM OF OPINION OF OGIER REGARDING THE VALIDITY OF THE ORDINARY SHARES BEING REG ea125531ex5-1_universepharm.htm EX-5.1 38718
6 FORM OF EMPLOYMENT AGREEMENT BY AND BETWEEN EXECUTIVE OFFICERS AND THE REGISTRAN ea125531ex10-1_universepharm.htm EX-10.1 52485
7 FORM OF INDEMNIFICATION AGREEMENT WITH THE REGISTRANT'S DIRECTORS AND OFFICERS ea125531ex10-2_universepharm.htm EX-10.2 47336
8 ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT BETWEEN JIANGXI UNIVERS ea125531ex10-3_universepharm.htm EX-10.3 118370
9 ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT BETWEEN UNIVERSE TRADE ea125531ex10-4_universepharm.htm EX-10.4 116089
10 ENGLISH TRANSLATION OF THE LOAN GUARANTEE CONTRACT AMONG JIANGXI UNIVERSE, XING ea125531ex10-5_universepharm.htm EX-10.5 80817
11 ENGLISH TRANSLATION OF THE LOAN GUARANTEE CONTRACT AMONG GANG LAI, LIN YANG, JIA ea125531ex10-6_universepharm.htm EX-10.6 76478
12 FORM OF SALES AND DISTRIBUTION AGREEMENT BY AND BETWEEN UNIVERSE TRADE AND CUSTO ea125531ex10-7_universepharm.htm EX-10.7 27341
13 SUBSIDIARIES ea125531ex21-1_universepharm.htm EX-21.1 3027
14 CONSENT OF FRIEDMAN LLP ea125531ex23-1_universepharm.htm EX-23.1 2906
15 CODE OF BUSINESS CONDUCT AND ETHICS OF THE REGISTRANT ea125531ex99-1_universepharm.htm EX-99.1 112965
16 OPINION OF ALLBRIGHT LAW OFFICES, PEOPLE'S REPUBLIC OF CHINA COUNSEL TO THE REGI ea125531ex99-2_universepharm.htm EX-99.2 25132
17 CONSENT OF FROST AND SULLIVAN ea125531ex99-3_universepharm.htm EX-99.3 6006
18 INDUSTRY REPORT BY FROST AND SULLIVAN ea125531ex99-4_universepharm.htm EX-99.4 29266
19 CONSENT OF JIAWEN PANG ea125531ex99-5_universepharm.htm EX-99.5 2486
20 CONSENT OF YONGPING YU ea125531ex99-6_universepharm.htm EX-99.6 3422
21 CONSENT OF DING ZHENG ea125531ex99-7_universepharm.htm EX-99.7 3418
22 GRAPHIC logo_001.jpg GRAPHIC 57592
23 GRAPHIC logo_002.jpg GRAPHIC 3714
24 GRAPHIC image_001.jpg GRAPHIC 33493
25 GRAPHIC image_002.jpg GRAPHIC 81053
26 GRAPHIC image_003.jpg GRAPHIC 24136
27 GRAPHIC image_004.jpg GRAPHIC 18618
28 GRAPHIC image_005.jpg GRAPHIC 14301
29 GRAPHIC image_006.jpg GRAPHIC 20017
30 GRAPHIC image_007.jpg GRAPHIC 19549
31 GRAPHIC image_008.jpg GRAPHIC 22074
32 GRAPHIC image_009.jpg GRAPHIC 2001
33 GRAPHIC image_010.jpg GRAPHIC 1876
34 GRAPHIC image_011.jpg GRAPHIC 1477
35 GRAPHIC fimg_01.jpg GRAPHIC 3877
36 GRAPHIC ex3-1_001.jpg GRAPHIC 59625
37 GRAPHIC ex3-2_001.jpg GRAPHIC 59230
38 GRAPHIC ex10-3_001.jpg GRAPHIC 1798
39 GRAPHIC ex10-3_002.jpg GRAPHIC 15500
40 GRAPHIC ex10-3_003.jpg GRAPHIC 6728
41 GRAPHIC ex10-3_004.jpg GRAPHIC 29143
42 GRAPHIC ex10-4_001.jpg GRAPHIC 1462
43 GRAPHIC ex10-4_002.jpg GRAPHIC 20154
44 GRAPHIC ex10-4_003.jpg GRAPHIC 6657
45 GRAPHIC ex10-4_004.jpg GRAPHIC 29143
46 GRAPHIC ex10-5_001.jpg GRAPHIC 2403
47 GRAPHIC ex10-5_002.jpg GRAPHIC 20198
48 GRAPHIC ex10-5_003.jpg GRAPHIC 27424
49 GRAPHIC ex10-6_001.jpg GRAPHIC 8526
50 GRAPHIC ex10-6_002.jpg GRAPHIC 24710
51 GRAPHIC ex10-6_003.jpg GRAPHIC 11579
52 GRAPHIC ex10-6_004.jpg GRAPHIC 3259
53 GRAPHIC ex10-6_005.jpg GRAPHIC 16150
54 GRAPHIC ex10-6_006.jpg GRAPHIC 17519
55 GRAPHIC ex10-7_001.jpg GRAPHIC 1605
56 GRAPHIC ex99-3_001.jpg GRAPHIC 6258
57 GRAPHIC ex99-4_001.jpg GRAPHIC 1250279
58 GRAPHIC ex99-4_002.jpg GRAPHIC 294251
59 GRAPHIC ex99-4_003.jpg GRAPHIC 187710
60 GRAPHIC ex99-4_004.jpg GRAPHIC 299279
61 GRAPHIC ex99-4_005.jpg GRAPHIC 709522
62 GRAPHIC ex99-4_006.jpg GRAPHIC 589811
63 GRAPHIC ex99-4_007.jpg GRAPHIC 299832
64 GRAPHIC ex99-4_008.jpg GRAPHIC 1119206
65 GRAPHIC ex99-4_009.jpg GRAPHIC 683675
66 GRAPHIC ex99-4_010.jpg GRAPHIC 689661
67 GRAPHIC ex99-4_011.jpg GRAPHIC 572917
68 GRAPHIC ex99-4_012.jpg GRAPHIC 1055923
69 GRAPHIC ex99-4_013.jpg GRAPHIC 416568
70 GRAPHIC ex99-4_014.jpg GRAPHIC 1379977
71 GRAPHIC ex99-4_015.jpg GRAPHIC 303386
72 GRAPHIC ex99-4_016.jpg GRAPHIC 929852
73 GRAPHIC ex99-4_017.jpg GRAPHIC 1054246
74 GRAPHIC ex99-4_018.jpg GRAPHIC 758425
75 GRAPHIC ex23-1_001.jpg GRAPHIC 25264
76 GRAPHIC ex99-2_001.jpg GRAPHIC 7258
  Complete submission text file 0001213900-20-022480.txt   21908549
Mailing Address 265 JINGJIU AVENUE JINGJIJISHU KAIFA DISTRICT, JINGGANGSHAN JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGJIJISHU KAIFA DISTRICT, JINGGANGSHAN JI'AN, JIANGXI F4 343100 86-0796-8404999
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: F-1 | Act: 33 | File No.: 333-248067 | Film No.: 201109468
SIC: 2834 Pharmaceutical Preparations